Pharmaceuticals

Key Market Drivers, Trends, and Forecast for the Global Artificial Intelligence (AI) In Predictive Toxicology Industry

September 1, 2025 by Marketing Posting

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#What Is the Outlook for the Artificial Intelligence (AI) In Predictive Toxicology Market Heading Into 2029?#_x000D_

In the past few years, there has been a notable increase in the size of the psoriasis market. The market is set to expand from $26.45 billion in 2024 to $28.93 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.4%. The surge in growth during the historical phase can be ascribed to factors such as epidemiology, increased patient consciousness and education, and the development and accessibility of the healthcare infrastructure._x000D_

_x000D_

Anticipations are running high for a robust expansion of the psoriasis market in the upcoming years. The market value is set to burgeon to “$40.93 billion by 2029, reflecting a compound annual growth rate (CAGR) of 9.1%. The projected growth during this period is driven by factors such as regulatory clearances, consumer inclinations, an aging society, heightened consciousness, and the debut of innovative therapies. The period is likely to witness significant trends such as progress in R&D, adoption of biologics and targeted therapies, deployment of oral small molecule treatments, the rise of personalized medicine, the advent of telemedicine and digital health, patient-directed care, emergence of biosimilars, and the integration of artificial intelligence and machine learning._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=2414&type=smp_x000D_

_x000D_

#Which Factors Are Pushing The Artificial Intelligence (AI) In Predictive Toxicology Market Forward?#_x000D_

Anticipated growth in the artificial intelligence (AI) in predictive toxicology market is largely due to the rising necessity for efficient and ethical drug discovery methods. Drug discovery is a multifaceted and evolving procedure involving the detailed study, production, and assessment of chemical compounds in order to unearth viable therapeutic agents for disease relief and general health improvement. This advanced and responsible approach to drug discovery is motivated by the growing prevalence of chronic illnesses, the emerging trend toward personalized medicine and an increase in age-related diseases. AI in predictive toxicology enhances drug discovery by proficiently examining extensive datasets to anticipate potential toxicological results, thus expediting the drug development process while upholding ethical practices. As an illustration, in June 2023, the pharmaceutical R&D expenditure in Europe was reported to be $49,500 million (€44,500 million), a roughly 6.45% increase from $46,500 million (€42,533 million) in 2021, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based pharmaceutical industry trade association. This growing necessity for efficient and ethical drug discovery procedures, therefore, is fueling the rise of AI in predictive toxicology market._x000D_

_x000D_

The psoriasis market covered in this report is segmented – _x000D_

_x000D_

1) By Drug class: Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor _x000D_

2) By Drug Types: Small molecules, Biologics _x000D_

3) By Disease Indication: Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis _x000D_

4) By Route Of Administration: Oral, Tropical, Injectable _x000D_

5) By Distribution Channel: Hospitals, Retail Pharmacies, E-Commerce_x000D_

_x000D_

Subsegments:_x000D_

1) By Interleukin Inhibitors: IL-12/23 Inhibitors (Ustekinumab), IL-17 Inhibitors (Secukinumab, Ixekizumab) _x000D_

2) By Corticosteroids: Topical Corticosteroids (Hydrocortisone, Betamethasone), Systemic Corticosteroids (Prednisone) _x000D_

3) By Anti-Inflammatory: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Biologic Anti-Inflammatory Agents (Apremilast) _x000D_

4) By Tumor Necrosis Factor (TNF) Inhibitors: Adalimumab (Humira), Etanercept (Enbrel), Infliximab (Remicade) _x000D_

_x000D_

#What Are The Leading Trends And Opportunities In The Artificial Intelligence (AI) In Predictive Toxicology Sector?#_x000D_

In the psoriasis market, the utilization of combination therapy is a rising trend. This form of treatment introduces two separate psoriasis treatments simultaneously. The use of two drugs with distinctive mechanisms in combination therapy results in an effect that surpasses that of monotherapy (usage of a solitary drug). Research infers that the effectiveness of combination therapy in alleviating psoriasis symptoms exceeds that of single therapy, and it also has fewer side effects. Taltz (ixekizumab) and methotrexate, developed by Eli Lilly and Company, is a prime example of combination therapy implemented for the treatment of active psoriatic arthritis (PsA)._x000D_

_x000D_

#Which Organizations Are Driving Progress In The Artificial Intelligence (AI) In Predictive Toxicology Industry?#_x000D_

Major companies operating in the psoriasis market include AbbVie Inc., Pfizer Inc., Novartis AG, Eli Lilly and Company, Celgene Corporation, Johnson & Johnson, Amgen Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Janssen Biotech Inc., Takeda Pharmaceutical Company Limited, Stiefel Laboratories Inc., AstraZeneca Inc., Union Chimique Belge SA, Sun Pharmaceutical Industries Ltd., Forward Pharma AS, Almirall SA, Bausch Health Companies Inc., Biogen Inc., Biocon Biopharmaceuticals Pvt. Ltd., Celltrion Inc., Dr.Reddy’s Laboratories Inc., Arcutis Biotherapeutics Inc., Bayer AG, Bristol Myers Squibb Co., Dermira Inc., Galderma SA, GlaxoSmithKline Plc, Incyte Pharmaceuticals Corp., LEO Pharmacy_x000D_

_x000D_

https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report_x000D_

_x000D_

#Which Region Is Expected To Experience The Highest Growth In The Artificial Intelligence (AI) In Predictive Toxicology Industry?#_x000D_

North America was the largest region in the psoriasis market in 2024. Middle East is expected to be the fastest-growing region in the psoriasis market during the forecast period. The regions covered in the psoriasis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=2414&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_